site stats

Tegatrabetan

WebDescription: Tegatrabetan, also known as Tegavivint and BC2059, is an orally bioavailable and potent β-catenin inhibitor. BC2059 potently induces apoptosis as a single agent and … WebTegatrabetan (BC2059) is a β-Catenin antagonist. Tegatrabetan disrupts the binding of β-catenin with the scaffold protein transducin β-like 1 (TBL1).

NCB-0846 CAS 1792999-26-8 AbMole BioScience NCB-0846 …

WebTegatrabetan (BC2059) is a β-Catenin antagonist. Tegatrabetan disrupts the binding of β-catenin with the scaffold protein transducin β-like 1 (TBL1). Stability and Solubility Advice: … WebTegatrabetan is an orally bioavailable and potent β-catenin inhibitor. BC2059 potently induces apoptosis as a single agent and in combination with bortezomib in multiple … sushi spinnery wiki https://a1fadesbarbershop.com

Tegatrabetan CAS:1227637-23-1 Probechem Biochemicals

WebJan 12, 2024 · For research use only. We do not sell to patients. Tegatrabetan. CAS No. : 1227637-23-1. Biological Activity:Tegatrabetan (BC2059) is a β-Catenin antagonist.Tegatrabetan disrupts the binding of β-catenin with the scaffold protein transducin β-like 1 (TBL1). WebIn vitro, tegatrabetan directly stimulates β-catenin degradation. In culture, tegatrabetan induces the apoptosis of desmoid tumor cells. A phase I/II trial is planned. The gamma-secretase inhibitor PF-03084014 stimulates the Notch pathway, which interacts with and indirectly regulates the Wnt/APC/β-catenin pathway. Tegatrabetan (BC2059) is a β-Catenin antagonist. Tegatrabetan disrupts the binding of β-catenin with the scaffold protein transducin β-like 1 (TBL1) [1] . Tegatrabetan (BC2059; 20-100 nM; 48 hours) inhibits cell proliferation in suspension culture over 120 hours and induces apoptosis of cultured human acute myeloid leukemia (AML) HL-60, OCI ... sushi spicy

Tegatrabetan Tegavivint BC2059 CAS#1227637-23-1 …

Category:Tegavivint C28H36N4O6S2 - PubChem

Tags:Tegatrabetan

Tegatrabetan

Tegatrabetan from Biorbyt Biocompare.com

WebTegatrabetan (BC-2059, BC2059, Tegavivint) is an orally bioavailable β-catenin antagonist that disrupts the binding of β-catenin to TBL1 and promotes β-catenin degradation, attenuates nuclear and cytoplasmic levels of β-catenin. BC-2059 reduces transcriptional activity of TCF4 and expression of its target genes, cyclin D1, c-MYC and survivin. WebTegatrabetan. Tegatrabetan (BC2059) is a β-Catenin antagonist. Tegatrabetan disrupts the binding of β-catenin with the scaffold protein transducin β-like 1 (TBL1). CWP232228. CWP232228, a highly potent selective Wnt/β-catenin signaling inhibitor, antagonizes binding of β-catenin to T-cell factor (TCF) in the nucleus.

Tegatrabetan

Did you know?

WebMechanism of action of tegatrabetan is shown. from publication: Recent Advances in Desmoid Tumor Therapy The desmoid tumor is a locally aggressive proliferative disease within the family of soft ... WebJan 12, 2024 · For research use only. We do not sell to patients. Tegatrabetan. CAS No. : 1227637-23-1. Biological Activity:Tegatrabetan (BC2059) is a β-Catenin …

WebTegatrabetan –TREATED CELL Transcription Turned “OFF” 4 Tegatrabetan Binds in Pocket 1 Kicks Out Beta Catenin, SMRT and NCOR Re-attach 2 ‘Free’ Beta Catenin … WebCompare Tegatrabetan from Biorbyt on Biocompare.com. Specifications/Features Application Notes: Tegatrabetan (BC-2059, BC2059, Tegavivint) is an orally bioavailable β-catenin antagonist that disrupts the binding of β-catenin to TBL1 and promotes β-catenin degradation, attenuates nuclear and cytoplasmic levels of β-catenin.

WebDescription: Tegatrabetan(also known as Tegavivint; BC-2059; BC 2059; BC2059) is an orally bioavailable and potent β-catenin inhibitor with potential anticancer activity.BC2059 potently induces apoptosis as a single agent and in combination with bortezomib in multiple myeloma. BC2059 induced apoptosis in 10/10 genetically heterogeneous human … WebTegatrabetan –TREATED CELL Transcription Turned “OFF” 4 Tegatrabetan Binds in Pocket 1 Kicks Out Beta Catenin, SMRT and NCOR Re-attach 2 ‘Free’ Beta Catenin Proteolyzed 3 ADVANTAGES Hydrophobic Pockets Allow Our Inhibitor to Bind Directly to TBL1 and Displace Beta Catenin; Free Beta Catenin is Immediately Proteolyzed TBL1 …

WebIn Vivo Tegatrabetan (BC2059; 1.0 or 5.0 mg/kg/day; intravenously) significantly improves the median survival of the mice from approximately 17.5 to 39 days. Treatment with …

WebTegatrabetan (BC-2059, BC2059, Tegavivint) is an orally bioavailable ?-catenin antagonist. Target : Beta-catenin. CAS Number : 1227637-23-1. Formula Weight : 588.74 sushi spider rollWebMar 3, 2024 · This phase Ib trial is to find out the best dose, possible benefits and/or side effects of osimertinib and tegavivint as first-line therapy in treating patients with EGFR-mutant non-small cell lung cancer that has spread to other places in the body (metastatic). sushi spinnery guideWebTegatrabetan. Catalog No. T5642 CAS 1227637-23-1. Synonyms: BC2059. BC2059 is a small molecule inhibitor of the Wnt/beta-catenin pathway with potential antineoplastic … sushi spinnery best layout